Investigators found sex and racial differences in the risk for end-stage kidney disease among patients with CKD anemia. Anemia may lead to chronic kidney disease (CKD) progression and kidney failure, ...

dementia Additional studies are needed to determine whether anemia itself is a risk factor for dementia in the CKD population. Anemia in patients with chronic kidney disease (CKD) portends an ...

A SURVEY of 36 proved cases of renal cancer has been made to determine the importance of fever and anemia as diagnostic signs in this disease. All patients underwent operations: nephrectomy in 35 and ...

daily multivitamin does not reduce the risks of cvd in men Iron therapy and erythropoiesis-stimulating agents are not always effective for anemia in patients with CKD. Nutritional interventions may be ...

Members of Congress introduce a bill to force Medicare to cover a drug they say will protect CKD patients during the COVID-19 pandemic. CMS’ decision to exclude a treatment for renal anemia from ...

The US Food and Drug Administration (FDA) has approved daprodustat (Jesduvroq), the first oral treatment for anemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at ...

The presence and severity of anemia in kidney disease increasesmarkedly with lower estimated glomerular filtration rates (eGFRs) and is associated with multiple adverse outcomes, a large cohort study ...

Please provide your email address to receive an email when new articles are posted on . It is an exciting time in the treatment of renal anemia, with several new therapies recently launched or ...

Please provide your email address to receive an email when new articles are posted on . Researchers from Denmark found the presence of anemia was associated with an increased risk for incident ...

Akebia Therapeutics (NASDAQ:AKBA) shares surged over 25% premarket on Thursday after the U.S. Food and Drug Administration (FDA) approved its Vafseo (vadadustat) tablets for the treatment of anemia ...

Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Renal Anemia Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ...